Physician profile
Brian W Luft
NPI 1063498061
$3,492.27
in general payments reported to CMS, 2019-2025
49 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $459 · 2021: $160 · 2022: $142 · 2023: $554 · 2024: $807 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,800.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $448.90 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $346.77 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $287.10 | 2019-2025 | |
| Qol Medical, LLC | $166.05 | 2023-2024 | Sucraid, Sucraid |
| Novo Nordisk INC | $157.17 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $153.19 | 2019-2024 | |
| Abbott Laboratories | $152.16 | 2019-2023 | Freestyle Libre 3, Infinity |
| Medtronic, INC. | $137.85 | 2021-2024 | Minimed 780g |
| Amgen INC. | $135.07 | 2019-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $128.24 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $108.42 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $89.95 | 2019-2025 | Camzyos, Eliquis |
| Corcept Therapeutics | $84.39 | 2020-2024 | Korlym |
| Radius Health, INC. | $67.06 | 2020-2023 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.03 | 2019-2025 | Jardiance |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $65.66 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.09 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $62.37 | 2023-2024 | Capvaxive, Gardasil 9, Gardasil |
| Inspire Medical Systems, INC. | $57.82 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $55.46 | 2019-2024 | Shingrix, Arexvy |
| Teva Pharmaceuticals USA, INC. | $54.92 | 2019-2024 | Ajovy |
| Takeda Pharmaceuticals U.S.A., INC. | $53.69 | 2019-2020 | |
| Allergan, INC. | $46.80 | 2019-2020 | |
| Lundbeck LLC | $36.94 | 2023-2024 | Rexulti |
| Dexcom, INC. | $36.26 | 2024-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $30.03 | 2020-2025 | Nexletol |
| Edwards Lifesciences Corporation | $28.29 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cequr Corporation | $26.02 | 2024 | Cequr Simplicity |
| Renalytix Ai, INC. | $22.21 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Beta Bionics, INC. | $22.16 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sunovion Pharmaceuticals INC. | $21.71 | 2019 | |
| Neuronetics, INC. | $20.26 | 2020 | |
| Exact Sciences Corporation | $18.60 | 2024 | Cologuard Collection Kit |
| Clarus Therapeutics INC. | $18.54 | 2021 | |
| Sanofi Pasteur INC. | $17.69 | 2023 | |
| Amneal Pharmaceuticals LLC | $17.50 | 2025 | Unithroid |
| Mylan Specialty L.P. | $17.33 | 2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $16.72 | 2019 | |
| Grifols USA, LLC | $15.88 | 2024 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $15.06 | 2025 | Symbravo |
| Tactile Systems Technology INC | $15.00 | 2025 | Nimbl, Flexitouch Plus |
| Aimmune Therapeutics, INC. | $14.62 | 2025 | Zenpep |
| Medtronic Minimed, INC. | $14.19 | 2020 | |
| Grt US Holding, INC. | $13.59 | 2022 | |
| Ibsa Pharma INC. | $13.38 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.94 | 2023 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $12.91 | 2020 | |
| Scilex Pharmaceuticals INC. | $12.24 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Luft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.